Predictive factors for live birth in donor oocyte-recipient cycles

Predictive factors for live birth in donor oocyte-recipient cycles
The use of IVF with donor oocytes has become an increasingly common treatment modality for women who are unable to conceive using their own oocytes. Data from the Society for Assisted Reproductive Technology (SART) in the United States demonstrate that >9,000 donor oocyte-recipient cycles were initiated in 2014 and 2015. The International Committee for Monitoring Assisted Reproductive Technologies (ICMART) also reported 133,679 donor oocyte-recipient cycles between 2008 and 2010 in 40 countries, with an overall increase of 35.8% cycles between 2008 and 2010 (1).
Source: fertstert.org